These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 37109487)

  • 1. Gut Microbiota in Autophagy Regulation: New Therapeutic Perspective in Neurodegeneration.
    Mitra S; Munni YA; Dash R; Sadhu T; Barua L; Islam MA; Chowdhury D; Bhattacharjee D; Mazumder K; Moon IS
    Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
    Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
    Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic Insights Into Gut Microbiome Dysbiosis-Mediated Neuroimmune Dysregulation and Protein Misfolding and Clearance in the Pathogenesis of Chronic Neurodegenerative Disorders.
    Padhi P; Worth C; Zenitsky G; Jin H; Sambamurti K; Anantharam V; Kanthasamy A; Kanthasamy AG
    Front Neurosci; 2022; 16():836605. PubMed ID: 35281490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.
    Koszewicz M; Jaroch J; Brzecka A; Ejma M; Budrewicz S; Mikhaleva LM; Muresanu C; Schield P; Somasundaram SG; Kirkland CE; Avila-Rodriguez M; Aliev G
    Pharmacol Res; 2021 Feb; 164():105277. PubMed ID: 33166735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drosophila as a Model for Microbiota Studies of Neurodegeneration.
    Kitani-Morii F; Friedland RP; Yoshida H; Mizuno T
    J Alzheimers Dis; 2021; 84(2):479-490. PubMed ID: 34569965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease.
    Sun P; Su L; Zhu H; Li X; Guo Y; Du X; Zhang L; Qin C
    Microorganisms; 2021 Nov; 9(11):. PubMed ID: 34835406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Gut Microbiota and Gut-Brain Interplay in Selected Diseases of the Central Nervous System.
    Doroszkiewicz J; Groblewska M; Mroczko B
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Dysbiosis to Neurodegenerative Diseases through Different Communication Pathways: An Overview.
    Intili G; Paladino L; Rappa F; Alberti G; Plicato A; Calabrò F; Fucarino A; Cappello F; Bucchieri F; Tomasello G; Carini F; Pitruzzella A
    Biology (Basel); 2023 Jan; 12(2):. PubMed ID: 36829474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometry-based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders.
    Luan H; Wang X; Cai Z
    Mass Spectrom Rev; 2019 Jan; 38(1):22-33. PubMed ID: 29130504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases.
    Gubert C; Kong G; Renoir T; Hannan AJ
    Neurobiol Dis; 2020 Feb; 134():104621. PubMed ID: 31628992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
    Goyal D; Ali SA; Singh RK
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State of the art in research on the gut-liver and gut-brain axis in poultry.
    Beldowska A; Barszcz M; Dunislawska A
    J Anim Sci Biotechnol; 2023 Apr; 14(1):37. PubMed ID: 37038205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bidirectional crosstalk between dysbiotic gut microbiota and systemic lupus erythematosus: What is new in therapeutic approaches?
    Yaigoub H; Fath N; Tirichen H; Wu C; Li R; Li Y
    Clin Immunol; 2022 Nov; 244():109109. PubMed ID: 36087683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota-derived metabolites as key mucosal barrier modulators in obesity.
    Wei YX; Zheng KY; Wang YG
    World J Gastroenterol; 2021 Sep; 27(33):5555-5565. PubMed ID: 34588751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total Flavones of
    Tu Y; Fang QJ; Sun W; Liu BH; Liu YL; Wu W; Yee HY; Yuan CC; Wang MZ; Wan ZY; Tang RM; Wan YG; Tang HT
    Front Pharmacol; 2020; 11():566611. PubMed ID: 33101025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut-Brain-Microbiota Axis and Hypertension: A Literature Review.
    Kwon YN; Kim YJ
    Curr Pharm Des; 2021; 27(37):3939-3946. PubMed ID: 34727853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
    Parodi B; Kerlero de Rosbo N
    Front Immunol; 2021; 12():718220. PubMed ID: 34621267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysbiosis of Gut Microbiota from the Perspective of the Gut-Brain Axis: Role in the Provocation of Neurological Disorders.
    Kandpal M; Indari O; Baral B; Jakhmola S; Tiwari D; Bhandari V; Pandey RK; Bala K; Sonawane A; Jha HC
    Metabolites; 2022 Nov; 12(11):. PubMed ID: 36355147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease.
    Zheng SY; Li HX; Xu RC; Miao WT; Dai MY; Ding ST; Liu HD
    Ageing Res Rev; 2021 Aug; 69():101347. PubMed ID: 33905953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons to Learn from the Gut Microbiota: A Focus on Amyotrophic Lateral Sclerosis.
    Calvo AC; Valledor-Martín I; Moreno-Martínez L; Toivonen JM; Osta R
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.